Jiangsu HengRui Medicine Co., Ltd.: Overweight trials

The registry lists 16 Overweight studies with Jiangsu HengRui Medicine Co., Ltd. as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 10Phase 2 5Phase 3 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal ImpairmentRecruitingNCT07807059Phase 1
• A Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in ObesityNot yet recruitingNCT07690826Phase 2
• Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight SubjectsRecruitingNCT07150962Phase 1
• A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-5817 InjectionRecruitingNCT06934408Phase 1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With ObesityActive, not recruitingNCT07559136Phase 1
• A Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple DosesActive, not recruitingNCT07280936Phase 1
• A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight SubjectsCompletedNCT07269756Phase 1
• A Trial of HRS-7535 Tablets in Subjects With Overweight or ObesityCompletedNCT06904105Phase 3
• The Evaluation of Bioequivalence Between a Single-dose Pen and a Multi-dose Pen of HRS9531 Injection SolutionCompletedNCT06792955Phase 1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy SubjectsCompletedNCT06762600Phase 1
• A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese SubjectsCompletedNCT06621316Phase 1/2
• A Study of Single and Multiple Doses HRS9531 Tablets in Healthy SubjectsCompletedNCT06435676Phase 1
• To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or ObeseCompletedNCT06396429Phase 3
• Efficacy and Safety of HRS-7535 Tablets in Obese Subjects .CompletedNCT06250946Phase 2
• Efficacy and Safety of HRS9531 Injections in Overweight or Obese SubjectsCompletedNCT06054698Phase 2
• A Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Obese Subjects Without DiabetesCompletedNCT05881837Phase 2